Reliability and validity of the Migraine Therapy Assessment Questionnaire

Headache

Volumn 42, Issue 10, 2002, Pages 1006-1015

  Chatterton, Mary Lou ^a   Lofland, Jennifer H ^b   Shechter, Aaron ^c   Curtice, Walter Scott ^b   Hu, X Henry ^d   Lenow, Jeffrey ^c   Smullens, Jeffrey ^e   Nash, David B ^b   Silberstein, Stephen D ^c  

^a MLG Consulting Services Inc   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Jefferson Health System Inc   (United States)

Author keywords

Disease management; Migraine; MTAQ; Reliability; Validity

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; ECONOMIC ASPECT; EMERGENCY TREATMENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; STATISTICS; VALIDATION PROCESS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PHILADELPHIA; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0036865387     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02230.x     Document Type: Article

References (29)

1. de Lissovoy G, Lazarus SS. The economic cost of migraine: Present state of knowledge. Neurology. 1994; 44(suppl. 4):S56-S62.
2. Solomon GD. Quality of life assessment in patients with headache. Pharmacoeconomics. 1994;6:34-41.
3. Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labor costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67-76.
4. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999;159:813-8.
5. Dahlof C. Assessment of health-related quality of life in migraine. Cephalalgia. 1993;13:233-237.
6. Osterhaus JT, Townsend RJ, Gandek B, Ware JE. Measuring the functional status and well being of patients with migraine headache. Headache. 1994;34:337-343.
7. Cohen JA, Beall DG, Miller, DW, et al. Sumatriptan in the treatment of migraine in an HMO setting: An investigation of economic, humanistic, and clinical outcomes. Clin Therap. 1999;21:190-204.
8. Adelman JU, Sharfman M, Johnson R, et al. Impact of oral sumatriptan on workplace productivity, health-related quality of life, healthcare use, and patient satisfaction with medication in nurses with migraine. Am J Manag Care. 1996;2:1407-1416.
9. Litaker DG, Solomon GD, Genzen JR. Impact of sumatriptan on clinic utilization and costs of care in migraineurs. Headache. 1996;36:538-541.
10. Greiner DL, Addy SN. Sumatriptan use in a large group-model health maintenance organization. Am J Health Syst Pharm. 1996;53:633-638.
11. Mushet GR, Miller D, Clements B, Pait G, Gutterman DL. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache. 1995;36:136-143.
12. Cortelli P, Dahlof C, Bouchard J, et al. A multinational investigation of the impact of subcutaneous sumatriptan III: Workplace productivity and non-workplace activity. Pharmacoeconomics. 1997;11(suppl. 1):35-42.
13. Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait G. Sumatriptan injection reduces productivity loss during a migraine attack: Results of a double blind, placebo-controlled trial. Arch Intern Med. 1998;158:1013-1018.
14. Cohen JA, Beall DG, Miller DW, Beck A, Pait G, Clements BD. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam Med. 1996;28:171-177.
15. Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Pract. 1996;42:36-42.
16. Solomon GD, Nielsen K, Miller DW. The effects of sumatriptan on migraineurs' health-related quality of life: A review of data from clinical trials. Med Interface. 1995;8:134-141.
17. Solomon GD, Skobieranda FG, Genzen JR. Quality-of-life assessment among migraine patients treated with sumatriptan. Headache. 1995;35:449-454.
18. Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia. 1997;17:867-872.
19. American Academy of Neurology. AAN Headache Guidelines. www.aan.com
20. Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches: A comparison of symptom based and reported physician diagnosis. Arch Intern Med. 1992;156:1273-1278.
21. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-328.
22. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Care Med. 1999;160:1647-1652.
23. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl. 7):1-96.
24. Ware JE Jr, Snow KK, Kosinski M, Gandek B. Reliability, Precision, and Data Quality, SF-36® Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute; 1993:12.
25. Lipton RB, Stamford CT, Stewart WF. Clinical utility of a new instrument assessing migraine disability: The migraine disability assessment score (MIDAS). American Association for the Study of Headache, 40th Annual Meeting, San Francisco, California, June 26-28, 1998.
26. Kendall PC, Hollon SD, Beck AT, Hammen CL, Ingram RE. Issues and recommendations regarding use of the Beck Depression Inventory. Cogn Ther Res. 1987;11:289-298.
27. Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill: 1994.
28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159.
29. Ware JE Jr, Bjorner JB, Kosinski M. Practical implications of item response theory and computerized adaptive testing: A brief summary of ongoing studies of widely used headache impact scales [comment]. Med Care. 2000;38(9 suppl.):1173-1182.